Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Liposomal Doxorubicin|Efficacy|Safety|Postoperative Adjuvant Treatment
Interventions: DRUG: Liposomal doxorubicin containing regimen
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University